Singulair 10mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food. It's essential to continue taking this medication even when you're not experiencing symptoms.
If you're taking this medication to prevent breathing problems that occur with exercise, be sure to take it at least 2 hours before physical activity. If you're using this medication to manage asthma, take it in the evening as directed.
Storing and Disposing of Your Medication
To maintain the quality and effectiveness of your medication, store it at room temperature, protected from light. Keep it in a dry place, avoiding storage in a bathroom. Store your medication in its original container to preserve its potency.
What to Do If You Miss a Dose
If you miss a dose, skip it and return to your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take montelukast once daily in the evening, even if you feel well. For exercise-induced bronchoconstriction, take at least 2 hours before exercise, but do not take another dose within 24 hours.
- Montelukast is NOT for treating sudden asthma attacks. Always carry your rescue inhaler (e.g., albuterol) for acute attacks.
- Continue to use your other asthma medications (e.g., inhaled corticosteroids) as prescribed, unless your doctor tells you otherwise.
- Avoid known asthma triggers (e.g., allergens, smoke, cold air).
- Maintain a healthy lifestyle, including regular exercise (if medically appropriate) and a balanced diet.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
New or worsening trouble breathing
Fever
Flu-like symptoms
Sinus pain
Abnormal burning, numbness, or tingling sensations
Ear pain
Other Possible Side Effects
Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor or seek medical help:
Headache
Stomach pain or diarrhea
Signs of a common cold
Cough
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Worsening asthma symptoms or increased need for rescue inhaler
- New or worsening mood changes (e.g., agitation, aggression, anxiety, depression, irritability)
- Sleep disturbances (e.g., nightmares, insomnia)
- Behavioral changes (e.g., restlessness, tremor)
- Suicidal thoughts or actions
- Signs of an allergic reaction (e.g., rash, itching, swelling, severe dizziness, trouble breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your current medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
Precautions & Cautions
It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
If you are pregnant, planning to become pregnant, or are breastfeeding, you must discuss the potential benefits and risks of this medication with your doctor, as they relate to both you and your baby.
Special Considerations for Breathing Problems
If you experience worsening breathing problems, a decrease in the effectiveness of your rescue inhaler, or an increased need to use your rescue inhaler, contact your doctor immediately.
If you are taking this medication for asthma or allergies, do not take an additional dose to prevent exercise-induced breathing problems.
If you have asthma and experience worsening symptoms when taking aspirin, it is recommended that you avoid aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, while taking this medication.
Transitioning from Steroid Medication
If you are switching to this medication from a steroid, do not abruptly stop taking the steroid. Instead, your doctor may need to gradually reduce the steroid dosage to minimize potential side effects. It is essential to consult with your doctor to determine the best course of action.
Overdose Information
Overdose Symptoms:
- Abdominal pain
- Somnolence (drowsiness)
- Thirst
- Headache
- Vomiting
- Psychomotor hyperactivity
What to Do:
Seek immediate medical attention or call Poison Control at 1-800-222-1222. There is no specific antidote; treatment is supportive.
Drug Interactions
Moderate Interactions
- Phenobarbital
- Rifampin
- Gemfibrozil
Monitoring
Baseline Monitoring
Rationale: To establish baseline lung function for asthma control assessment.
Timing: Prior to initiation of therapy
Rationale: To establish baseline symptom severity.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Regularly (e.g., monthly or as clinically indicated)
Target: Improved symptom control, reduced rescue inhaler use, improved quality of life
Action Threshold: Worsening symptoms, increased rescue inhaler use, or lack of improvement may indicate need for re-evaluation or alternative therapy.
Frequency: Ongoing, at each visit
Target: Absence of new or worsening behavioral changes, agitation, aggression, depression, suicidal ideation/behavior.
Action Threshold: Any new or worsening neuropsychiatric symptoms warrant immediate discontinuation and medical evaluation.
Symptom Monitoring
- Asthma symptoms (wheezing, shortness of breath, cough, chest tightness)
- Allergic rhinitis symptoms (sneezing, runny nose, nasal congestion, itching)
- Mood changes (agitation, aggression, anxiety, depression, irritability)
- Sleep disturbances (insomnia, nightmares)
- Behavioral changes (restlessness, tremor)
- Suicidal thoughts or actions
Special Patient Groups
Pregnancy
Montelukast is Pregnancy Category B. Studies in animals have shown no evidence of harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed and the potential benefits outweigh the potential risks.
Trimester-Specific Risks:
Lactation
Montelukast is excreted into human breast milk. The amount is very small, and adverse effects on the breastfed infant are unlikely. However, monitor the infant for potential adverse effects such as irritability or rash. Use with caution.
Pediatric Use
Approved for use in children as young as 6 months of age. Dosing is weight/age-dependent. Neuropsychiatric events, including suicidal ideation, have been reported in pediatric patients; careful monitoring is essential.
Geriatric Use
No dosage adjustment is generally required in elderly patients. The safety and efficacy profile is similar to that in younger adults. However, elderly patients may be more sensitive to drug effects and should be monitored for adverse reactions.
Clinical Information
Clinical Pearls
- Montelukast is a maintenance medication and should not be used for acute asthma attacks. Patients should always have a rescue inhaler available.
- Emphasize the importance of taking the medication consistently every evening, even when symptoms are controlled.
- Educate patients and caregivers about the potential for neuropsychiatric side effects (e.g., mood changes, aggression, suicidal thoughts) and instruct them to report any such symptoms immediately to their healthcare provider. Discontinuation may be necessary.
- While generally well-tolerated, some patients may experience headache, abdominal pain, or upper respiratory infection symptoms.
- Montelukast can be used as monotherapy for mild persistent asthma or as add-on therapy for moderate to severe persistent asthma not adequately controlled by inhaled corticosteroids.
Alternative Therapies
- Inhaled Corticosteroids (e.g., fluticasone, budesonide) - cornerstone of asthma management
- Long-Acting Beta-Agonists (LABAs) (e.g., salmeterol, formoterol) - often combined with ICS
- Short-Acting Beta-Agonists (SABAs) (e.g., albuterol) - for rescue relief
- Other Leukotriene Modifiers (e.g., zafirlukast, zileuton - less commonly used due to side effects/dosing)
- Cromolyn sodium (mast cell stabilizer)
- Omalizumab (Xolair) - anti-IgE monoclonal antibody for severe allergic asthma
- Mepolizumab, Reslizumab, Benralizumab (anti-IL-5 biologics) - for severe eosinophilic asthma
- Dupilumab (anti-IL-4/IL-13 biologic)